Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Risk of immune-related adverse events associated with ipilimumab-plus-nivolumab and nivolumab therapy in cancer patients

Total article views   HTML views PDF downloads Totals
10,354 Dovepress* 6,657+ 2,105 8,762
PubMed Central* 3,697 514 4,211
Totals 10,354 2,619 12,973
*Since 31 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
2 1 0 0 0 1

View citations on PubMed Central and Google Scholar